Cemented TrendHip® - Multicenter PMCF Study on Total Indications

NCT04943328 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2026-02-24

No results posted yet for this study

Summary

This Post Market Clinical Follow-Up (PMCF) study to evaluate the performance and safety of the cemented TrendHip® stem in a prospective follow-up study with patients who underwent a hip arthroplasty with the investigational product (representative of usual clinical practice), at two follow-up examinations

Conditions

  • Coxarthrosis; Primary
  • Coxarthrosis; Post-Traumatic
  • Necrosis, Femur Head
  • Rheumatoid Arthritis
  • Fractures, Hip
  • Hip Dysplasia

Interventions

DEVICE

Total Hip Arthroplasty

cemented hip arthroplasty

Sponsors & Collaborators

  • Aesculap AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-12
Primary Completion
2023-05-08
Completion
2028-05-08

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04943328 on ClinicalTrials.gov